Guidance on the management of clinical trials during the COVID-19 (Coronavirus) pandemic
The document sets out to include most of the current guidance across Member States with the aim of serving as a harmonised EU-level set of recommendations.
Read the news announcement published by the European Commission on 10 February 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (15 mars 2022). Guidance on the management of clinical trials during the COVID-19 (Coronavirus) pandemic. ELSIBI. Consulté le 16 janvier 2025 à l’adresse https://doi.org/10.58079/o5wt
